Parkinson’s disease afflicts up to a million people in the United States. Sixty thousand new cases are documented by doctors each year. Studies show that men are at 1.5 times greater risk than women. Also, the average age of onset is 60. Currently, there is not a cure for this devastating disease. Also, there are a lot of prescription and non-prescription drugs to alleviate some of the symptoms associated with the disease. Finally, Ultimate CBD Warehouse will show you how the effects of CBD may be able to help with Parkinson’s based on scientific research.
Parkinson’s disease has a progressive course characterized by the degeneration of dopaminergic neurons. Also, no neuroprotective treatments have been discovered, the endocannabinoid system has emerged as a promising target. The result, Cannabidiol enters the numerous options to help people.
A study found that there is a possible effect of CBD in improving quality of life measures in patients.
Also, another study concluded that cannabinoids seem to be able to treat at least some symptoms of the neurological disease.
Finally, scientific research in regards to Parkinson’s Disease and CBD is undeniable. Since the passing of the farm bill, more analysis can be performed to confirm what we now already know. In conclusion, Hemp CBD is beneficial in helping people.
Source(s):
Quick Hits | Project CBD. https://www.projectcbd.org/parkinsons-disease
Can CBD Help With Parkinson’s? The Research – Clinical Studies
Finally, the publishing of these studies was by the U.S. National Library of Medicine | National Institute of Health, a U.S. government health publishing website. Also, please click one of the documents below to review full clinical studies.
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial
- Cannabinoids in health and disease
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- Prospects for cannabinoid therapies in basal ganglia disorders
- Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: Importance of antioxidant and cannabinoid receptor-independent properties
- Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- Therapeutic potential of cannabinoids in CNS disease
- CB2 Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease
- Neurological aspects of medical use of CBD
